Moleculin Biotech Inc (MBRX)
2.45
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
2.43
-0.02
(-0.82%)
After-Hours: 20:00
Moleculin Biotech Free Cash Flow: -25.75M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -25.75M |
| March 31, 2024 | -24.92M |
| December 31, 2023 | -24.22M |
| September 30, 2023 | -25.99M |
| June 30, 2023 | -25.99M |
| March 31, 2023 | -28.91M |
| December 31, 2022 | -27.71M |
| September 30, 2022 | -24.71M |
| June 30, 2022 | -21.42M |
| March 31, 2022 | -20.14M |
| December 31, 2021 | -18.95M |
| September 30, 2021 | -17.83M |
| June 30, 2021 | -19.26M |
| March 31, 2021 | -17.43M |
| December 31, 2020 | -18.15M |
| September 30, 2020 | -19.69M |
| Date | Value |
|---|---|
| June 30, 2020 | -17.32M |
| March 31, 2020 | -17.73M |
| December 31, 2019 | -17.25M |
| September 30, 2019 | -15.79M |
| June 30, 2019 | -15.57M |
| March 31, 2019 | -13.67M |
| December 31, 2018 | -12.62M |
| September 30, 2018 | -11.80M |
| June 30, 2018 | -10.31M |
| March 31, 2018 | -8.776M |
| December 31, 2017 | -7.352M |
| September 30, 2017 | -6.126M |
| June 30, 2017 | -5.468M |
| March 31, 2017 | -4.866M |
| December 31, 2016 | -3.765M |
Free Cash Flow Range, Past 5 Years
-28.91M
Minimum
Mar 2023
-17.25M
Maximum
Dec 2019
-21.76M
Average
-20.14M
Median
Mar 2022
Free Cash Flow Benchmarks
| Agilent Technologies Inc | 1.417B |
| Seelos Therapeutics Inc | -13.27M |
| Cara Therapeutics Inc | -83.33M |
| Citius Pharmaceuticals Inc | -29.09M |
| NovaBay Pharmaceuticals Inc | -3.396M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.949M |
| Cash from Investing (Quarterly) | -0.013M |
| Cash from Financing (Quarterly) | -0.025M |
| Free Cash Flow Per Share (Quarterly) | -2.344 |
| Free Cash Flow Yield | -468.3% |